reference/32753272

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32753272

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	E1613
issn	0735-1097
issueIdentifier	6
pageRange	E1608-E1613
publicationName	Journal of the American College of Cardiology
startingPage	E1608
bibliographicCitation	Batchelor WB, Mahaffey KW, Berger PB, Deutsch E, Meier S, Hasselblad V, Fry ET, Teirstein PS, Ross AM, Binanay CA, Zidar JP; ATLAST Trial Investigators. A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial. J Am Coll Cardiol. 2001 Nov 15;38(6):1608–13. doi: 10.1016/s0735-1097(01)01612-6. PMID: 11704394.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9fd445f1f7fd7cd03d7fcf292d66bf8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7c94392bd07995be6adca5ef32457a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22de125895020d74c3a106f42777452c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56ae06ca5600e8abf53ac7c1381bfb09 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d21e08a87e0f36555c26403ed920fe58 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_456ed522b60fc0a10427727fd22ac350 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d12343989ce698f3efc7db9da2fd4022 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44098fcf6854cccb7cae941523df4a4c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8b4f3eca6fd3594c0cbec9120b53087 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ac8f9e5115576154927b139e5b3c1e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a673be71dc4c56ff4c225820d48dafc
date	2001-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/s0735-1097%2801%2901612-6 https://pubmed.ncbi.nlm.nih.gov/11704394
isPartOf	https://portal.issn.org/resource/ISSN/0735-1097 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4429
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial
discusses	http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0027160 http://id.nlm.nih.gov/mesh/M0021526 http://id.nlm.nih.gov/mesh/M0001380
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015607Q000009 http://id.nlm.nih.gov/mesh/D000925Q000627 http://id.nlm.nih.gov/mesh/D003328Q000517 http://id.nlm.nih.gov/mesh/D017984Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000925Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000925Q000008 http://id.nlm.nih.gov/mesh/D013988Q000627 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D000704 http://id.nlm.nih.gov/mesh/D003327Q000628 http://id.nlm.nih.gov/mesh/D004333 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D001241Q000627 http://id.nlm.nih.gov/mesh/D017984Q000009 http://id.nlm.nih.gov/mesh/D017984Q000008 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID772 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8166 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5472

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136116304 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298

Total number of triples: 66.